Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: April 1, 2023

Details for Patent: 8,722,037

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

Summary for Patent: 8,722,037
Title:X-ray visible drug delivery device
Abstract: The subject invention provides an X-ray visible drug delivery device for subdermal administration of a contraceptive or hormone replacement therapy.
Inventor(s): Veenstra; Harm (Oss, NL), De Graaff; Wouter (Oss, NL)
Assignee: Meck Sharp & Dohme B.V. (BN Harleem, NL)
Application Number:10/592,725
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,722,037
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device;

Drugs Protected by US Patent 8,722,037

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 31, 2011 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,722,037

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
04101151Mar 19, 2004
PCT Information
PCT FiledMarch 14, 2005PCT Application Number:PCT/EP2005/051150
PCT Publication Date:September 29, 2005PCT Publication Number: WO2005/089814

International Family Members for US Patent 8,722,037

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 048106 ⤷  Sign Up
Austria 399569 ⤷  Sign Up
Australia 2005224054 ⤷  Sign Up
Brazil PI0508865 ⤷  Sign Up
Canada 2559250 ⤷  Sign Up
China 1953770 ⤷  Sign Up
Cyprus 1108362 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.